Enzon Pharmaceuticals Revenue 2024

Enzon Pharmaceuticals Revenue

0 USD

Enzon Pharmaceuticals Dividend yield

207.49 %

Ticker

ENZN

ISIN

US2939041081

WKN

873997

In 2024, Enzon Pharmaceuticals's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.

The Enzon Pharmaceuticals Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2023--
2022--
20210.717171,43
20200.1120200,00
20190.260100,00
20186.91742,03
20178.41430,95
20168.41430,95
201517.5686,86
201431.2385,26
201334.5348,41
201242.6282,16
201148.1249,90
201097.9122,78
200951.4233,85
200857210,88
200765.2184,36
200667.9177,03
2005166.372,28
2004169.672,29

Enzon Pharmaceuticals Aktienanalyse

What does Enzon Pharmaceuticals do?

Enzon Pharmaceuticals Inc. is an American biotechnology company that has been active since 1981. They specialize in researching, developing, and marketing innovative medicines. The company operates primarily in the United States but is also internationally known and active. Enzon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Enzon Pharmaceuticals's Sales Figures

The sales figures of Enzon Pharmaceuticals originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Enzon Pharmaceuticals’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Enzon Pharmaceuticals's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Enzon Pharmaceuticals’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Enzon Pharmaceuticals Stock

How much revenue did Enzon Pharmaceuticals generate this year?

Enzon Pharmaceuticals has achieved a revenue of 0 USD this year.

How much was the turnover of the company Enzon Pharmaceuticals compared to the previous year?

The revenue of Enzon Pharmaceuticals has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Enzon Pharmaceuticals?

The revenue of Enzon Pharmaceuticals is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Enzon Pharmaceuticals measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Enzon Pharmaceuticals so important for investors?

The revenue of Enzon Pharmaceuticals is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Enzon Pharmaceuticals pay?

Over the past 12 months, Enzon Pharmaceuticals paid a dividend of 0.18 USD . This corresponds to a dividend yield of about 207.49 %. For the coming 12 months, Enzon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Enzon Pharmaceuticals?

The current dividend yield of Enzon Pharmaceuticals is 207.49 %.

When does Enzon Pharmaceuticals pay dividends?

Enzon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of January, October, March, October.

How secure is the dividend of Enzon Pharmaceuticals?

Enzon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Enzon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzon Pharmaceuticals located?

Enzon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzon Pharmaceuticals from 10/15/2019 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2019.

When did Enzon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/15/2019.

What was the dividend of Enzon Pharmaceuticals in the year 2023?

In the year 2023, Enzon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Enzon Pharmaceuticals pay out the dividend?

The dividends of Enzon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzon Pharmaceuticals

Our stock analysis for Enzon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.